Shield Therapeutics PLCHere is the public summary page for Shield Therapeutics PLC. Please login to see the complete information for Shield Therapeutics PLC including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Shield Therapeutics PLC stacks up relative to its peers. |
| Darwin Score | +15 |
| Ticker | STX |
| Latest Price | 0.05 GBP as of close on 28-Jul-2025 |
| 3 Month price range | 0.02 to 0.03 GBP |
| Market Capitalisation | 29.69Mn GBP |
| Country | United Great Britain and Northern Ireland |
| Region | Europe |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on commercialization of pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom. See More ... |
| Company URL | https://www.shieldtherapeutics.com |
| See Darwins Full Analysis for Shield Therapeutics PLC |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Shield Therapeutics PLC. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +15 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +1 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | -2 |
Peer Comparison
There are 4 peers of Shield Therapeutics PLC.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Angle PLC (AGL) | Biotechnology | -29 |
| Arecor Therapeutics PLC (AREC) | Biotechnology | +4 |
| Haleon PLC (HLN) | Biotechnology | +21 |
| Physiomics PLC (PYC) | Biotechnology | -3 |
Share 
